| 级别 | (仅限科学研究,不得用于临床及其人体治疗。) |
| 克隆性 | 多克隆 |
| 抗体英文名 | Adalimumab |
| 抗体名 | Adalimumab |
| 应用范围 | E |
| 规格 | 0.1mg |
Table 1. Biosimilar research antibodies
Biotherapeutic Antibody | Antibody Specificity | Bio-Rad Biosimilar (Cat. #) | Supporting Anti-Drug Antibodies |
|---|---|---|---|
Adalimumab | Human Anti-TNF alpha Antibody | ||
Alemtuzumab | Human Anti-CD52 Antibody | ||
Bevacizumab | Human Anti-VEGF Antibody | ||
Cetuximab | Human Anti-EGFR Antibody | ||
Eculizumab | Human Anti-C5 Antibody | Anti-Eculizumab Antibodies - Coming soon | |
Infliximab | Human Anti-TNF alpha Antibody | ||
Natalizumab | Anti-Integrin Alpha 4 Antibody | ||
Omalizumab | Human Anti-IgE Antibody | ||
Rituximab | Human Anti-CD20 Antibody | ||
Tocilizumab | Human Anti-IL6R Antibody | ||
Trastuzumab | Human Anti-ErbB2 Antibody |
Each biosimilar research antibody has been produced using a recombinant platform and incorporates the publicly available sequence of the variable region (specificity) of the original monoclonal antibody drug. These biosimilar products are supplied in a research grade format, i.e. in PBS buffer with preservative; they are not manufactured or formulated in the same way as the therapeutic reference product. A comparison of these antibodies with their respective therapeutic reference products was carried out to show biosimilarity, Figures 1 and 2.
All of our biosimilar research antibodies show comparable purity and monodispersity with the reference product. Purity was measured by band quantification of a Coomassie stained SDS-PAGE gel; monodispersity was compared using size exclusion chromatography (SEC). Example data for Anti-TNF alpha Antibody and adalimumab are shown in Figure 1. Detailed comparison data for each antibody with its reference product is available on the respective product information page accessed via the link in Table 1.